This paper reviews selected aspects of progress and setbacks in cancer risk assessment and prevention during the four decades since the founding in 1947 of the Institute of Environmental Medicine at the New York University Medical Center. The period has been marked by substantial gains in quantifying the risks posed by exposures to known human carcinogens such as tobacco and ionizing radiation. By contrast, the search for sensitive and specific laboratory screens for human carcinogens has met setbacks, and epidemiological data still are needed to monitor the adverse effects of environmental exposures. The determination of acceptable levels of exposure to potential human carcinogens remains a fornidable task, one for which no scientific fraxmework yet exists. Future challenges in cancer risk assessment include the validation and use of biological markers of exposure and effective monitoring of risk among exposed populations. Future challenges in cancer prevention include the elimination of tobacco consumption and the acquisition of knowledge needed to prevent nutritionally and hormonally related cancers such as cancers of the bowel, prostate, and breast.
Introduction
This year marks the fortieth anniversary of the Institute of Environmental Medicine at the New York University Medical Center. When the Institute began in 1947, the Western world had just turned its attention from a major war to domestic public health problems such as urban and industrial air pollution and occupational health hazards. A few clinicians were beginning to suspect that human cancers could be caused by exposures to tobacco, ionizing radiation, and chemicals encountered in the workplace. The past four decades have seen considerable research focused on our interaction with the environment and how it affects our health. The Institute of Environmental Medicine has distinguished itself as a leader in much of this research. At this fortieth anniversary celebration it is appropriate to inquire where we stand in the battle against environmentally induced cancer and to identify the major unfinished tasks before us. To address these questions, I shall review selected aspects of our progress and setbacks in evaluating human cancer risks from substances in the environment and describe some of the future challenges in cancer risk assessment and prevention. I shall use the word environment in a broad sense, allowing it to include ways of living such as tobacco use and diet. 
Detecting and Estimating Carcinogenic Risks
I shall begin with a discussion of progress and problems in risk estimation for two known human carcinogens: tobacco and radiation. I shall also give a brief overview of progress and problems in monitoring risk from potential carcinogens-that is, substances whose carcinogenic effect in humans is less certain.
Known Carcinogens: Tobacco
The beneficial/deleterious effects of tobacco have been debated since its introduction to Europe in the late sixteenth century. However, it was not until the late 1940s that the issue was studied epidemiologically. The year 1950 saw publication of results from five studies comparing the smoking habits of patients with cancers of the lung to those of control subjects (1) (2) (3) (4) (5) . These studies present strong evidence of a causal relationship. Results from subsequent cohort studies and animal experiments have established beyond reasonable doubt that cigarette smoking causes cancers of the mouth, esophagus, respiratory system, bladder, and pancreas. Experimental work in the Institute of Environmental Medicine at NYU by Van Duuren and his colleagues showed that many of the chemical constituents of cigarette smoke act as carcinogens, cocarcinogens, and promoters in mouse skin (6 Harley and Pasternack (10) postulated that the lung cancer rate induced by a single radon exposure is independent of time since exposure (after a short period during which no cancers occur). These researchers were among the first to note that radon-induced lung cancer rates increase with age at first exposure, an observation now sup- ported by the recent BEIR IV analysis of four cohorts of miners (11 The data on temporal effects of other forms of ionizing radiation are less clear. On the one hand, evidence from the cohort of atomie bomb survivors and the cohort given X-ray treatments for ankylosing spondylitis (13, 14) indicate excess rates that increase with age at irradiation and that remain constant with time since irradiation. These patterns suggest that a late-stage action also applies to the induction of nonhormonal epithelial cancers by all forms of ionizing radiation. However, the skin cancer data among children given X-ray treatment for ringworm of the scalp (15) indicate that radiation-induced rates increase sharply with time since irradiation, a temporal pattern more consistent with an early-stage effect of radiation. Further long-term follow-up of these irradiated cohorts is needed to test Peto's conjecture.
The temporal behavior of radiation-induced breast cancer rates differs from that of other epithelial cancers, according to data from cohorts of atomic bomb survivors, and of women X-irradiated for postpartum mastitis and tuberculosis (16, 17) . These suggest that risk is highest among women who were irradiated during adolescence, when breast epithelial cells are rapidly dividing. In contrast to the picture for radon and lung cancer, the breast cancer data also indicate that radiation-induced rates increase with time since exposure, suggesting that radiation induces an early neoplastic change in breast epithelial cells.
An important goal for future work is to develop a unifying theory for radiation-induced human carcinogenesis that allows reliable predictions of risk among various population subgroups. These predictions are needed to determine exposure limits and set priorities for abatement procedures.
All of the human data suggest that radiation-induced cancer rates are proportional to radiation dose, at least in the lower dose ranges. For radon, a linear doseresponse relationship implies relatively large lung cancer risks associated with indoor levels in U.S. homes. In reviewing all of the relevant epidemiological data, Thomas and McNeill (18) (22, 23) . The chlorinated ethers were singled out, and rodent experiments determined that BCME was the most carcinogenic. Because humans inhale this compound in occupational settings, further inhalation studies in rats were conducted (24) . These studies indicated that BCME was a lung carcinogen in rats. The results prompted an epidemiologic study of men occupationally exposed to BCME, which found an excess of lung cancer (25) . The totality of this work prevented cancers by allowing early introduction of protective measures.
The BCME experience and others like it raised hopes that human cancer risks could be controlled by eliminating chemicals that test positive in animal experiments. In an invited address to NYU Medical Center in 1974 entitled "Carcinogens are Mutagens," Bruce Ames raised the further possibility that short-term tests for mutagenicity and other genotoxic effects could screen for carcinogens (26) . Animal experiments could be supplemented or even replaced by rapid and inexpensive test batteries that would detect human carcinogens with high sensitivity and specificity.
These hopes have not been realized. Laboratory experiments are still imperfect tools for detecting human cancer, for several reasons. One is the great variability across species in response to chemicals and our lack of understanding about the causes of this variability. The International Agency for Research on Cancer has determined that there is sufficient evidence from human observations, but limited, inadequate, or nonexistent evidence from animal experiments to classify as carcinogens the compounds listed in Thble 1. The fact that most of these compounds have tested positive in one or more of the short-term tests reflects not the sensitivity of the test battery, but rather the intense scrutiny the compounds have received relative to those for which no human data are available.
Another shortcoming of laboratory tests as screens for human carcinogens is their lack of specificity; one or more of them have tested positive for a number of chemicals occurring naturally in the foods we eat and the products we use. This lack of specificity is related to the inability of laboratory work to mimic the complex mix of carcinogens and cocarcinogens to which human cells are exposed. We now know that response to one carcinogen depends on other exposures, endogenous hormone levels, and myriad other factors. Work conducted at NYU and elsewhere has revealed a variety of pathways through which carcinogens work on somatic cells. These include nuclear effects such as the formation of DNA adducts and oncogene expression, and extranuclear effects such as mitotic acceleration. For example, experimental mouse skin carcinogenesis indicates that the dose-response curve for initiating carcinogens can be altered by the presence of other promoting agents (27) .
For all of these reasons, laboratory tests do not yet provide a reliable screen for human carcinogens, and human data continue to be needed, despite the obvious desirability of discovering hazards before human exposure to them. In particular, occupationally exposed populations should be monitored routinely for cancer risks, as described in the next section. The most promising developments in the monitoring of exposed populations involve the use of biological exposure markers in blood, tissue, urine, feces, hair, or nail samples, as discussed elsewhere in this symposium (28) . Such markers have the potential to document exposure levels, identify and quantify unusual susceptibility to environmental toxicants, detect neoplastic precursors, and provide etiologically supportive links between exposure and disease.
Although early hopes for a simple and consistent laboratory test battery were overoptimistic, laboratory tests nevertheless make important contributions to risk assessment. Specifically, they provide chemical profiles useful in evaluating potential human risks. This is not to imply that such profiles can produce precise estimates of human cancer numbers associated with low exposures. We still have no scientific basis for such estimation, but in our ignorance we have no choice but to use the profiles for crude and comparative estimates of risk.
For example, recent risk estimates have been based on comparative potency, whereby chemicals are ranked relative to one another. Relative ranks in humans at low doses are assumed equal to those in other test systems at experimental doses (30, 31) . This method has been used by Albert and colleagues at the Environmental Protection Agency to estimate human lung cancer risk from diesel particulate emissions (30) . Several investigators have proposed that we regard as de minimus those levels of a carcinogen calculated to produce no more risk than that associated with an exposure we now tolerate, e.g., the amount of chloroform accepted in drinking water by the Environmental Protection Agency (29, 31) . The calculations are based on estimated potencies relative to that of chloroform. While not a panacea for the uncertainties created by lack of scientific evidence, this procedure seems a rational pro teem alternative to policies that effectively ban the use of all animal carcinogens. Laboratory experiments also are needed to validate biological markers of human exposure by correlating them with exposure and disease in controlled settings. Perhaps most importantly, they provide insight and guidance about carcinogenic mechanisms that is needed to motivate observational studies in humans.
Future Challenges in Cancer Prevention
The absence of reliable laboratory screens for human carcinogens mandates aggressive monitoring of exposed populations, such as certain occupational groups, patients undergoing chemotherapy, and those living near nuclear facilities and toxic waste dumps. In particular, industrial epidemiologists should work with industry physicians in keeping computerized, annually updated and linkable medical, job, and smoking histories for all current and former employees. Continued morbidity and mortality monitoring after retirement is particularly important in view of increasing trends in certain cancer rates among older age groups that cannot be explained by increased diagnostic accuracy (32) . Doll (33) U.S. white males. Each successive birth cohort contains fewer men who started smoking, and among those who did, a higher proportion who smoked low tar cigarettes. A different picture emerges for young women, whose smoking prevalence has increased within the past four decades. The increasing rates among young women shown in Figure 6 mark the start of an alarming rise in female lung cancers that will continue to manifest itself into the twenty-first century.
Equally alarming is the widespread use of smokeless tobacco by young men in the U.S. If not checked, this practice bodes an epidemic of oral cancer in the coming decades. Eliminating tobacco consumption is a major challenge in cancer prevention. In particular, all elementary and secondary schools should include programs on ways to cope with the peer pressures of tobacco use and on the health consequences of tobacco use.
Results from both experimental and epidemiological studies indicate that risk for cancers of the bowel and prostate may be amenable to manipulation by nutritional factors. However, the full picture needed for prevention
has not yet emerged. The search for chemopreventive foods is a worthwhile approach, because the prescription of certain exposures is inherently more appealing than the proscription of others. Work at NYU and elsewhere on the anticarcinogenic effects of vitamin A and its precursors, of the protease inhibitors in seeds and certain beans (34) (35) (36) (37) , and of the allyl sulfides in onion and garlic oils (38) provide promising first steps in reducing risk for these and other cancers.
.fOur current ignorance of the ways to prevent cancers the breast, bowel, and prostate mandates increased efforts to screen high risk populations (39, 40 
